Xiaosong Ding
Impact in
-
- Cardiovascular Function and Risk Factors
- Acute Myocardial Infarction Research
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Hyperglycemia and glycemic control in critically ill and hospitalized patients
Papers in
-
- Acute Myocardial Infarction Research 11
- Cardiovascular Function and Risk Factors 7
- Atrial Fibrillation Management and Outcomes 3
-
- Cardiac Imaging and Diagnostics 10
- Co-authors
- Hongwei Li (18 shared papers)Weiping Li (13 shared papers)Qingbo Liu (7 shared papers)Hui Chen (10 shared papers)Bing Hua (5 shared papers)Hui Gao (3 shared papers)Xue-Qiao Zhao (7 shared papers)Hui Chen (3 shared papers)
- Journals
- Journal of Atherosclerosis and Thrombosis (2 papers)Journal of Translational Medicine (2 papers)Coronary Artery Disease (1 paper)Oncotarget (1 paper)Molecular Carcinogenesis (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaosong Ding
27 papers receiving 535 citations
Peers
Comparison fields: 5 of 72
- Cardiology and Cardiovascular Medicine 270
- Endocrinology, Diabetes and Metabolism 155
- Cancer Research 78
- Internal Medicine 19
- Radiology, Nuclear Medicine and Imaging 86
Countries citing papers authored by Xiaosong Ding
This map shows the geographic impact of Xiaosong Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaosong Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaosong Ding more than expected).
Fields of papers citing papers by Xiaosong Ding
This network shows the impact of papers produced by Xiaosong Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaosong Ding. The network helps show where Xiaosong Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaosong Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 73 | |
| 2 | 2021 | 64 | |
| 3 | 2019 | 64 | |
| 4 | 2019 | 47 | |
| 5 | 2019 | 42 | |
| 6 | 2021 | 42 | |
| 7 | 2020 | 39 | |
| 8 | 2014 | 29 | |
| 9 | 2017 | 19 | |
| 10 | 2019 | 15 | |
| 11 | 2012 | 14 | |
| 12 | 2017 | 12 | |
| 13 | 2020 | 11 | |
| 14 | 2021 | 10 | |
| 15 | 2019 | 9 | |
| 16 | 2020 | 7 | |
| 17 | 2016 | 7 | |
| 18 | 2022 | 6 | |
| 19 | 2022 | 5 | |
| 20 | 2021 | 5 |
About Xiaosong Ding
Xiaosong Ding is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging, Surgery, Molecular Biology and Epidemiology, having authored 29 papers that have together received 543 indexed citations. Recurring topics across this work include Acute Myocardial Infarction Research (11 papers), Cardiac Imaging and Diagnostics (10 papers), Cardiovascular Function and Risk Factors (7 papers), Coronary Interventions and Diagnostics (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers), Atrial Fibrillation Management and Outcomes (3 papers), Lipoproteins and Cardiovascular Health (3 papers) and Inflammatory Biomarkers in Disease Prognosis (2 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (270 citations), Endocrinology, Diabetes and Metabolism (155 citations), Cancer Research (78 citations), Internal Medicine (19 citations) and Radiology, Nuclear Medicine and Imaging (86 citations). Xiaosong Ding has collaborated with scholars based in China and United States. Frequent co-authors include Hongwei Li, Weiping Li, Qingbo Liu, Hui Chen, Bing Hua, Hui Gao, Xue-Qiao Zhao, Hui Chen, Xue‐Qiao Zhao and Hehe Cui. Their work appears in journals such as Journal of Atherosclerosis and Thrombosis, Journal of Translational Medicine, Coronary Artery Disease, Oncotarget and Molecular Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.